[Federal Register Volume 65, Number 194 (Thursday, October 5, 2000)]
[Notices]
[Pages 59430-59431]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-25687]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Committee on Immunization Practices: Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC)

[[Page 59431]]

announces the following committee meeting:

    Name: Advisory Committee on Immunization Practices (ACIP).
    Times and Dates: 8:30 a.m.-6:30 p.m., October, 18, 2000; 8 a.m.-
3:30 p.m., October 19, 2000.
    Place: Atlanta Marriott Century Center, 2000 Century Boulevard, 
NE., Atlanta, Georgia 30345-3377.
    Status: Open to the public, limited only by the space available.
    Purpose: The Committee is charged with advising the Director, 
CDC, on the appropriate uses of immunizing agents. In addition, 
under 42 U.S.C. 1396s, the Committee is mandated to establish and 
periodically review and, as appropriate, revise the list of vaccines 
for administration to vaccine-eligible children through the Vaccines 
for Children (VFC) program, along with schedules regarding the 
appropriate periodicity, dosage, and contraindications applicable to 
the vaccines.
    Matters To Be Discussed: The agenda will include a discussion on 
the recommended childhood immunization schedule; immunization of 
foreign adoptees and progress towards recommending immunization of 
foreign adoptees; influenza vaccine supply for 2000-2001 season; 
1999-2000 season vaccine effectiveness; update on the live 
attenuated influenza vaccine and vaccine recommendations for young 
children; persistent poliovirus excretion in patients with B cell 
immune deficiency disorders; meningococcal conjugate vaccination in 
the United Kingdom; update on measles vaccination and outbreaks in 
the United Kingdom; anaphylaxis after Measles, Mumps, and Rubella 
vaccine due to gelatin; pertussis among adolescents and adults in 
the U.S.; review of recommendations for pneumococcal polysaccharide 
vaccination among HIV-positive adults; Adult Immunization Action 
Plan; smallpox vaccine recommendations in bioterrorism event 
involving smallpox, revised recommendations for smallpox vaccination 
in laboratory workers using attenuated vaccinia virus strains, 
alternatives to VIG for treatment of adverse vaccine reactions; 
Subcommittee on Oversight of the Vaccine Health Care Network; update 
on the National Immunization Program vaccine safety initiatives; 
update from the National Center for Infectious Diseases; update from 
the National Immunization Program; update from the Food and Drug 
Administration; update from the Vaccine Injury Compensation Program; 
and an update from the National Vaccine Program.
    Agenda items are subject to change as priorities dictate.
    Contact Person for More Information: Gloria A. Kovach, Program 
Analyst, Epidemiology and Surveillance Division, National 
Immunization Program, CDC,1600 Clifton Road, NE., m/s E61, Atlanta, 
Georgia 30333. Telephone 404/639-8096.
    The Director, Management Analysis and Services office has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities for both the Centers for Disease Control and Prevention 
and the Agency for Toxic Substances and Disease Registry.

    Dated: September 28, 2000.
Carolyn J. Russell,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 00-25687 Filed 10-4-00; 8:45 am]
BILLING CODE 4163-18-P